Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSPY22P is annotated as a pseudogene belonging to the "testis specific protein Y-linked" (TSPY) family. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations, deletions, or insertions that prevent them from encoding active proteins. While some pseudogenes have regulatory roles by acting as decoys or noncoding RNAs, there is no evidence that TSPY22P is transcribed or functional, nor is it associated with any disease mechanism, biological function, or therapeutic intervention in the scientific literature. This distinguishes it from the canonical TSPY1 gene, which functions as a proto-oncogene and cancer-testis antigen in male reproductive biology and certain cancers, but TSPY22P does not encode a protein and has no known biological relevance. If you are seeking a valid therapeutic target, TSPY1 (Testis specific protein Y-linked 1) is the related, functional gene relevant to cancer and male reproductive biology, not TSPY22P.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis specific protein Y-linked 22, pseudogene (TSPY22P).